Theratyping Cystic Fibrosis patients to guide Elexacaftor-Tezacaftor-Ivacaftor out of label prescription.
Elise DreanoPierre Regis BurgelAurélie HattonNaim BouazzaBenoit ChevalierJulie MaceySylvie LeroyIsabelle DurieuLaurence WeissDominique GrenetNathalie StremlerCamille OhlmannPhilippe ReixMichele PorzioPauline Roux ClaudeNatacha RémusBenoit DouvrySylvie MontcouquiolLaure CossonJulie MankikianJeanne LanguepinVeronique HoudouinLaurence Le ClaincheAnne GuillaumotDelphine PouradierAdrien TissotPascaline PriouLaurent MélyFrederique ChedevergneMuriel LebourgeoisJean LebihanClémance MartinFlora ZavalaJennifer Da SilvaLydie LemonnierMairead Kelly-AubertAnita GolecPierre FoucaudChristophe MarguetAleksander EdelmanAlexandre HinzpeterPaola di CarliEmmanuelle GirodonIsabelle Sermet-GaudelusIwona PrankePublished in: The European respiratory journal (2023)
Primary nasal epithelial cells hold promise for expanding CFTR modulators prescription in pwCF carrying rare mutants. Additional variants should be discussed for ETI indication.